CN107854484A - A kind of peritoneal dialysis solution - Google Patents

A kind of peritoneal dialysis solution Download PDF

Info

Publication number
CN107854484A
CN107854484A CN201711056132.6A CN201711056132A CN107854484A CN 107854484 A CN107854484 A CN 107854484A CN 201711056132 A CN201711056132 A CN 201711056132A CN 107854484 A CN107854484 A CN 107854484A
Authority
CN
China
Prior art keywords
peritoneal dialysis
dialysis solution
chloride
glucose
fucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201711056132.6A
Other languages
Chinese (zh)
Inventor
宋宏婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711056132.6A priority Critical patent/CN107854484A/en
Publication of CN107854484A publication Critical patent/CN107854484A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of peritoneal dialysis solution, belong to medical field of dialysis, including the 15%W/V of sodium chloride 10, calcium chloride be 0.2 5%W/V, potassium chloride is 2 5%W/V, sodium acid carbonate is 2 5%W/V, magnesium chloride 2 5%W/V, the 10W/V of fucose 2 and the glucose less than 5%W/V.

Description

A kind of peritoneal dialysis solution
Technical field
The present invention relates to field of dialysis, a kind of specifically peritoneal dialysis solution.
Background technology
Dialysis(dialysis)It is that water is diffused into through semi-permeable membrane by small molecule(Or buffer solution)Principle, by small molecule A kind of separating and purifying technology separated with large biological molecule.Dialysis therapy is to make the composition in body fluid(Solute or moisture)Pass through half The treatment method that permeable membrane excretes, it generally can be divided into two kinds of haemodialysis and peritoneal dialysis.
Peritoneal dialysis(Peritoneal dialysis, PD)Be by the use of human body itself peritonaeum as dialysis membrane one kind Dialysis.Solute and moisture are carried out by pouring into the plasma fraction in the dialyzate in abdominal cavity and the capillary of peritonaeum opposite side Exchange, remove the metabolite of internal retention and excessive moisture, while pass through dialyzate and supplement material necessary to body. By constantly updating peritoneal dialysis liquid, reach kidney replacement or the purpose of supportive treatment.
Existing peritoneal dialysis is mainly used as osmotic pressure agent by glucose, among the process of dialysis, part glucose meeting By body absorption so that blood glucose rise, among metabolic disorder, and sterilization process harmful substance caused by glucose to human body all There is very big influence, influence dialysis-effect, while dewatering is poor.
The content of the invention
It is an object of the invention to:For above-mentioned problem, there is provided a kind of peritoneal dialysis solution, it is characterised in that bag It is 2-5 %W/V to include sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, potassium chloride 2-5%W/V, sodium acid carbonate, chlorination Magnesium 2-5 %W/V, fucose 2-10 %W/V and the glucose less than 5%W/V.
Preferably, described fucose is 5-8% W/V, the concentration of glucose is less than 3%W/V.
Preferably, the concentration of each material is sodium chloride is 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2%W/V, Glucose is 2% W/V, and sodium acid carbonate is 3 %W/V.
Preferably, the concentration of each material is sodium chloride is 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, Portugal Grape sugar is 2% W/V, and fucose is that 8 %W/V sodium acid carbonates are 3 %W/V.
Preferably, the pH value in dialyzate is 5-8.
Preferably, pH value is 6-7.5.
The invention also discloses a kind of preparation method of dialyzate, comprise the following steps:
Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.
A kind of preparation method of peritoneal dialysis solution according to claim 6, it is characterised in that described miillpore filter Filtering particle diameter be 0.2-0.4 μm.
Embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiments, to the present invention It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to Limit the present invention.
Specific embodiment 1:A kind of peritoneal dialysis solution, including sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, chlorine Change potassium be 2-5%W/V, sodium acid carbonate be 2-5 %W/V, magnesium chloride 2-5 %W/V, fucose 2-10 %W/V and less than 5%W/V Glucose.Described fucose is 5-8% W/V, and the concentration of glucose is less than 3%W/V.
Specific embodiment 2:The concentration of each material be sodium chloride be 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2% W/V, glucose are 2% W/V, and fucose is 8 %W/V, and sodium acid carbonate is 3 %W/V, and pH value is adjusted to 7.
The concentration of 3 each material of specific embodiment be sodium chloride be 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, grape Sugar is 2% W/V, and fucose is that 8 %W/V sodium acid carbonates are 3 %W/V, and PH is adjusted to 6
Specific embodiment 4:Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.The filtering particle diameter of described miillpore filter is 0.2-0.4 μm.
Specific embodiment 5;Specific embodiment 5 is a comparative example relative to 2:The concentration of each material is sodium chloride It is 10% W/V for 10% W/V, calcium chloride 0.2%W/V, potassium chloride 2%W/V, glucose, sodium acid carbonate is 3 %W/V, pH value It is adjusted to 7.
Specific embodiment 6:It is a comparative example of embodiment 3:The concentration of each material is that sodium chloride is 12% W/V, chlorination Calcium is 2%W/V, potassium chloride 3%W/V, glucose are 10% W/V, and sodium acid carbonate is 3 %W/V, and PH is adjusted to 6.
In embodiment, tested with the white mouse of anesthesia, by 10ml, embodiment 2-3,5-6, injection white mouse is intraperitoneal, and 10 After hour, intraperitoneal liquid is reclaimed(Subtract the amount of liquid for anaesthetizing withdrawal liquid immediately), measure the liquid of embodiment 5 and embodiment 6 The scale of construction is respectively 42 and 56, and the amount of liquid that embodiment 2 and 3 reclaims is respectively 64 and 78.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention All any modification, equivalent and improvement made within refreshing and principle etc., should be included in the scope of the protection.

Claims (8)

1. a kind of peritoneal dialysis solution, it is characterised in that including sodium chloride 10-15% W/V, calcium chloride 0.2-5%W/V, potassium chloride It is 2-5 %W/V, magnesium chloride 2-5 %W/V, fucose 2-10 %W/V and the Portugal less than 5%W/V for 2-5%W/V, sodium acid carbonate Grape sugar.
2. peritoneal dialysis solution according to claim 1, it is characterised in that described fucose is 5-8% W/V, glucose Concentration be less than 3%W/V.
3. peritoneal dialysis solution according to claim 2, it is characterised in that the concentration of each material is that sodium chloride is 10% W/ V, calcium chloride be 0.2%W/V, potassium chloride 2%W/V, glucose be 2% W/V, sodium acid carbonate is 3 %W/V.
4. peritoneal dialysis solution according to claim 1, it is characterised in that the concentration of each material is
Sodium chloride is 12% W/V, calcium chloride 2%W/V, potassium chloride 3%W/V, glucose are 2% W/V, and fucose is 8 %W/V Sodium acid carbonate is 3 %W/V.
5. peritoneal dialysis solution according to claim 4, it is characterised in that the pH value in dialyzate is 5-8.
6. peritoneal dialysis solution according to claim 5, it is characterised in that pH value 6-7.5.
7. the preparation method of the peritoneal dialysis solution according to claim any one of 1-5, it is characterised in that including following step Suddenly:
Step 1: other materials in addition to fucose and glucose and water are mixed, homogeneous solution is formed;
Step 2: sterilization treatment is carried out at high temperature;
Step 3: adding fucose and glucose, homogeneous solution is formed;
Step 4: use filtering with microporous membrane.
8. the preparation method of a kind of peritoneal dialysis solution according to claim 6, it is characterised in that described miillpore filter It is 0.2-0.4 μm to filter particle diameter.
CN201711056132.6A 2017-10-27 2017-10-27 A kind of peritoneal dialysis solution Withdrawn CN107854484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711056132.6A CN107854484A (en) 2017-10-27 2017-10-27 A kind of peritoneal dialysis solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711056132.6A CN107854484A (en) 2017-10-27 2017-10-27 A kind of peritoneal dialysis solution

Publications (1)

Publication Number Publication Date
CN107854484A true CN107854484A (en) 2018-03-30

Family

ID=61696446

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711056132.6A Withdrawn CN107854484A (en) 2017-10-27 2017-10-27 A kind of peritoneal dialysis solution

Country Status (1)

Country Link
CN (1) CN107854484A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890041A (en) * 2010-02-10 2010-11-24 上海蓝怡科技有限公司 Peritoneal dialysis solution and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890041A (en) * 2010-02-10 2010-11-24 上海蓝怡科技有限公司 Peritoneal dialysis solution and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
韩明亮,等: "《食品化学》", 30 September 2005, 延边大学出版社 *
顾学裘,等: "《药物制剂注解》", 31 May 1983, 人民卫生出版社 *

Similar Documents

Publication Publication Date Title
JP4778681B2 (en) Bicarbonate-based solutions for dialysis therapy
CN105992599B (en) Cylindrantherae for cleaning dialysis solutions
KR101813740B1 (en) Dialysis precursor composition
CA2741572C (en) Portable peritoneal dialysis system
CN105008893B (en) PH buffer measuring system for hemodialysis system
WO2011130528A1 (en) Anticoagulant-free dialysis systems and methods
CN108430529A (en) system and method for extracorporeal blood treatment
WO2014113740A1 (en) Removal of carbon dioxide via dialysis
JP2003534052A (en) Medical carbohydrate solutions and bisulfite stabilizers in multi-compartment containers and uses thereof
CN107854484A (en) A kind of peritoneal dialysis solution
CN107854483A (en) A kind of preparation method of peritoneal dialysis solution
CN107854482A (en) A kind of high peritoneal dialysis solution of dehydration rate
HUT68062A (en) Method and liquids includiug hydrochloric acid for hemodialysis, and concentrate of two container for hemodialysing equipment
CN114869906A (en) Dialysis concentrate and preparation and quality detection method thereof
CN103932981A (en) Heparin sodium tube-sealing injection
CN109078019B (en) Bicarbonate dialysate packaged by double-chamber bag and preparation method thereof
CN107854481A (en) A kind of collocation method of blood dialysis solution
KR101978010B1 (en) Dialysis precursor composition
CN107684558A (en) A kind of blood dialysis solution
CN107890471A (en) A kind of anticoagulant hemodialysis liquid
KR101978011B1 (en) Dialysis precursor composition
CN205145229U (en) Hemodialyzer
Zulkarnaev A brief history of the study of diffusion and osmosis in the context of dialysis
Ota et al. A new method of urea removal using urease and expanded polytetrafluoroethylene membrane
Kobayashi et al. FP535 EFFECT OF CONTACT WITH A VITAMIN E-COATED DIALYSIS MEMBRANE ON THE GENE EXPRESSION PFOFILE OF MONOCYTES

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20180330

WW01 Invention patent application withdrawn after publication